Thus, the p14 fragment levels were still comparable to the low levels seen during chemotherapy-induced cytopenia/bone marrow failure, whereas for endocan there was a reduction but not a complete normalization compared with the increased levels observed for patients with untreated acute leukemia. The gene discussed is ESM1; the disease is acute leukemia.